Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (553)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
135
2025
2998
9.920
Why?
Gene Expression Regulation, Neoplastic
53
2025
833
3.280
Why?
Drug Resistance, Neoplasm
25
2020
316
3.140
Why?
Gene Expression Profiling
43
2023
1025
2.760
Why?
Cell Proliferation
25
2022
985
2.190
Why?
Plasma Cells
23
2025
221
2.180
Why?
Antineoplastic Agents
29
2020
1172
2.110
Why?
Cell Line, Tumor
46
2025
1398
1.950
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
112
1.890
Why?
Neoplastic Stem Cells
7
2020
98
1.650
Why?
Pyrazines
19
2023
188
1.560
Why?
Paraproteinemias
9
2024
72
1.430
Why?
Mice
46
2025
5687
1.420
Why?
Lymphoma, B-Cell
5
2021
49
1.410
Why?
Apoptosis
18
2025
1097
1.380
Why?
Disease Progression
18
2024
829
1.370
Why?
Humans
155
2025
50503
1.350
Why?
Boronic Acids
17
2014
183
1.350
Why?
Bone Resorption
6
2024
302
1.350
Why?
Tumor Microenvironment
6
2024
222
1.240
Why?
Animals
57
2025
13124
1.230
Why?
Neoplasm Proteins
7
2021
320
1.180
Why?
Prognosis
36
2024
1978
1.120
Why?
Osteolysis
4
2022
74
1.100
Why?
B-Lymphocytes
8
2021
171
1.070
Why?
Cell Cycle Proteins
4
2023
161
1.020
Why?
T-Lymphocytes
8
2024
325
0.990
Why?
Hematopoietic Stem Cell Transplantation
6
2024
578
0.980
Why?
Ubiquitination
3
2021
42
0.930
Why?
Proteasome Inhibitors
7
2020
104
0.910
Why?
Signal Transduction
21
2023
1624
0.870
Why?
MicroRNAs
7
2022
344
0.820
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.820
Why?
Antigens, CD
8
2024
222
0.760
Why?
Neoplasms
3
2024
1251
0.740
Why?
Carrier Proteins
3
2017
298
0.670
Why?
CDC2-CDC28 Kinases
3
2015
11
0.660
Why?
Cation Transport Proteins
2
2019
27
0.640
Why?
Up-Regulation
6
2020
446
0.620
Why?
Ubiquitins
2
2016
39
0.620
Why?
Cyclin-Dependent Kinases
2
2010
26
0.620
Why?
Mice, Inbred NOD
5
2020
91
0.610
Why?
Glycolysis
3
2022
69
0.610
Why?
Oligonucleotide Array Sequence Analysis
19
2014
405
0.610
Why?
Waldenstrom Macroglobulinemia
1
2018
40
0.600
Why?
Chromosome Aberrations
6
2023
280
0.590
Why?
Proto-Oncogene Proteins c-akt
5
2023
156
0.590
Why?
Cell Differentiation
9
2023
640
0.590
Why?
Iron
2
2017
121
0.580
Why?
STAT3 Transcription Factor
4
2016
77
0.570
Why?
Pyrimidines
3
2015
191
0.570
Why?
Killer Cells, Natural
5
2024
106
0.560
Why?
Cell Survival
10
2020
589
0.560
Why?
Ascorbic Acid
1
2017
21
0.550
Why?
Pyruvate Kinase
1
2017
7
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1000
0.540
Why?
RNA Splicing
1
2017
38
0.540
Why?
Protein-Tyrosine Kinases
2
2015
88
0.510
Why?
Down-Regulation
9
2019
340
0.500
Why?
Cyclopentanes
1
2015
10
0.500
Why?
Transplantation, Autologous
5
2024
481
0.490
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
67
0.490
Why?
Thalidomide
10
2023
378
0.490
Why?
Aldehyde Dehydrogenase
1
2014
25
0.480
Why?
Osteoclasts
7
2023
427
0.470
Why?
Dexamethasone
7
2024
432
0.460
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.460
Why?
Female
44
2024
27081
0.440
Why?
Models, Biological
5
2018
716
0.440
Why?
Hematologic Neoplasms
1
2015
99
0.430
Why?
Receptors, Retinoic Acid
2
2013
22
0.430
Why?
Cystatin M
2
2024
19
0.430
Why?
Male
34
2024
25907
0.430
Why?
RNA, Messenger
13
2021
1089
0.420
Why?
Flow Cytometry
8
2018
474
0.410
Why?
B-Cell Maturation Antigen
2
2024
99
0.410
Why?
Antigens, Neoplasm
6
2014
148
0.410
Why?
Glucuronidase
4
2018
48
0.400
Why?
Predictive Value of Tests
5
2016
930
0.380
Why?
Mice, Transgenic
6
2021
540
0.370
Why?
Antibodies, Bispecific
2
2023
88
0.370
Why?
Syndecan-1
6
2017
75
0.360
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.360
Why?
Arsenicals
1
2010
14
0.360
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.360
Why?
Oxides
1
2010
18
0.360
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
572
0.350
Why?
Janus Kinase 1
1
2010
16
0.350
Why?
Proto-Oncogene Proteins c-jun
2
2009
77
0.350
Why?
MAP Kinase Kinase 1
1
2010
23
0.340
Why?
Immunotherapy, Adoptive
2
2024
163
0.340
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.340
Why?
DNA-Binding Proteins
4
2021
418
0.340
Why?
Early Growth Response Protein 1
1
2009
34
0.330
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
90
0.320
Why?
Transcription Factors
6
2022
565
0.320
Why?
Tretinoin
1
2009
50
0.320
Why?
Oligopeptides
3
2015
95
0.310
Why?
Xenograft Model Antitumor Assays
7
2019
212
0.310
Why?
NF-kappa B
3
2018
315
0.300
Why?
Osteogenesis
5
2023
356
0.300
Why?
Genes, Neoplasm
1
2008
27
0.300
Why?
Tumor Cells, Cultured
6
2020
457
0.300
Why?
Antibodies
3
2024
153
0.290
Why?
Microarray Analysis
3
2018
70
0.290
Why?
Aged
24
2024
9741
0.290
Why?
Chromosomes, Human, Pair 1
4
2023
92
0.280
Why?
Immunologic Factors
5
2015
111
0.280
Why?
Interleukin-6
3
2019
261
0.280
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.280
Why?
Neoplasms, Plasma Cell
2
2023
36
0.280
Why?
Tumor Suppressor Protein p53
2
2008
213
0.280
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Pyrazoles
2
2020
111
0.270
Why?
Mice, SCID
9
2018
178
0.260
Why?
Protein Kinase Inhibitors
3
2024
204
0.250
Why?
CD8-Positive T-Lymphocytes
3
2024
125
0.250
Why?
Endopeptidase Clp
1
2025
2
0.250
Why?
Risk Factors
11
2018
3724
0.250
Why?
Genomics
2
2023
279
0.240
Why?
Survival Rate
8
2020
909
0.240
Why?
Enzyme Inhibitors
4
2019
377
0.240
Why?
Middle Aged
23
2024
12611
0.240
Why?
Bone Diseases
4
2016
96
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Bone Marrow
7
2024
363
0.230
Why?
Single-Cell Analysis
1
2025
63
0.230
Why?
Receptors, LDL
1
2024
67
0.220
Why?
Hydroxybenzoates
1
2024
18
0.220
Why?
Propionates
1
2024
22
0.220
Why?
Ferritins
1
2024
30
0.220
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.220
Why?
Myeloid Progenitor Cells
1
2023
17
0.220
Why?
X-Ray Microtomography
1
2024
79
0.220
Why?
Cholesterol
1
2024
150
0.220
Why?
Melphalan
3
2023
178
0.220
Why?
Histocompatibility Antigens Class I
2
2015
46
0.220
Why?
Antigens, CD19
3
2018
29
0.220
Why?
Neoplasms, Second Primary
1
2024
74
0.220
Why?
Bone Marrow Cells
4
2015
196
0.220
Why?
Cell Transformation, Neoplastic
1
2024
181
0.210
Why?
Membrane Glycoproteins
6
2009
245
0.210
Why?
Proto-Oncogene Proteins c-myc
3
2025
50
0.210
Why?
Genes, myc
3
2019
32
0.210
Why?
Intercellular Signaling Peptides and Proteins
4
2007
102
0.210
Why?
Lymphoma
1
2024
67
0.210
Why?
Bone Diseases, Metabolic
1
2024
74
0.210
Why?
Phenols
1
2024
82
0.210
Why?
Cluster Analysis
5
2009
219
0.210
Why?
Homeostasis
1
2024
204
0.210
Why?
Gene Knockdown Techniques
3
2018
105
0.210
Why?
Bone and Bones
2
2021
478
0.210
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.210
Why?
Recurrence
7
2018
659
0.200
Why?
Protein Binding
2
2018
654
0.200
Why?
Neutropenia
1
2023
116
0.200
Why?
Periodontitis
1
2022
13
0.200
Why?
Randomized Controlled Trials as Topic
6
2016
573
0.200
Why?
In Situ Hybridization, Fluorescence
5
2023
231
0.200
Why?
Antibodies, Monoclonal
3
2013
462
0.200
Why?
Reactive Oxygen Species
4
2017
409
0.200
Why?
Case-Control Studies
8
2020
1156
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.190
Why?
Protein Stability
2
2020
43
0.190
Why?
Kaplan-Meier Estimate
5
2016
464
0.190
Why?
Osteoporosis
1
2023
156
0.190
Why?
Mitochondria
1
2025
399
0.190
Why?
Arthritis, Rheumatoid
1
2022
106
0.190
Why?
Adult
20
2024
13577
0.190
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.190
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.190
Why?
RANK Ligand
1
2022
187
0.180
Why?
Ubiquitin-Protein Ligases
2
2020
95
0.180
Why?
Venous Thromboembolism
3
2011
74
0.180
Why?
Oxidative Stress
4
2016
772
0.180
Why?
Phenylpropionates
1
2021
13
0.180
Why?
Hippurates
1
2021
10
0.180
Why?
Gene Expression
4
2017
610
0.180
Why?
Cell Cycle
4
2010
226
0.180
Why?
Membrane Proteins
3
2017
332
0.180
Why?
Proteolysis
3
2017
96
0.180
Why?
Bone Neoplasms
2
2015
179
0.180
Why?
Colonic Neoplasms
1
2022
158
0.180
Why?
Adaptor Proteins, Signal Transducing
1
2021
198
0.180
Why?
Protease Inhibitors
3
2011
58
0.180
Why?
Cell Movement
2
2015
247
0.180
Why?
Treatment Outcome
12
2020
5283
0.180
Why?
Colorectal Neoplasms
2
2022
260
0.180
Why?
Receptors, G-Protein-Coupled
1
2021
49
0.180
Why?
Antigens, CD20
2
2014
6
0.180
Why?
Neoplasm Metastasis
4
2015
232
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
46
0.170
Why?
Retrospective Studies
7
2024
6263
0.170
Why?
Time Factors
8
2021
2935
0.170
Why?
Disease-Free Survival
7
2016
444
0.170
Why?
Evolution, Molecular
1
2021
95
0.170
Why?
Chromosomal Instability
3
2021
16
0.170
Why?
Cytotoxicity, Immunologic
4
2015
55
0.170
Why?
Tumor Suppressor Proteins
2
2019
128
0.170
Why?
Clinical Trials as Topic
1
2022
486
0.170
Why?
Neoplasm Recurrence, Local
1
2024
629
0.170
Why?
DNA, Single-Stranded
1
2020
89
0.160
Why?
NF-E2-Related Factor 2
1
2019
40
0.160
Why?
Oncogene Proteins
1
2019
16
0.160
Why?
Mitosis
3
2015
88
0.160
Why?
Carcinoma, Neuroendocrine
1
2019
23
0.160
Why?
Transplantation, Heterologous
2
2017
75
0.160
Why?
rab GTP-Binding Proteins
1
2019
35
0.160
Why?
Receptors, Interleukin-6
1
2018
22
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Pyridines
1
2019
131
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Neovascularization, Pathologic
3
2009
155
0.150
Why?
Blotting, Western
3
2015
578
0.150
Why?
Lung Neoplasms
1
2024
601
0.150
Why?
Drug Therapy, Combination
2
2017
384
0.140
Why?
beta Catenin
2
2015
97
0.140
Why?
Mice, Knockout
4
2023
844
0.140
Why?
M Phase Cell Cycle Checkpoints
1
2017
4
0.140
Why?
Hydroxamic Acids
2
2014
37
0.140
Why?
Aerobiosis
1
2017
14
0.140
Why?
Microfilament Proteins
1
2017
42
0.140
Why?
Onium Compounds
1
2016
13
0.140
Why?
Thyroid Hormones
1
2017
20
0.140
Why?
Calcium-Binding Proteins
1
2017
55
0.140
Why?
Organophosphorus Compounds
1
2016
15
0.140
Why?
Deoxyglucose
1
2016
36
0.140
Why?
Histone Deacetylase Inhibitors
2
2014
56
0.140
Why?
Survival Analysis
6
2020
661
0.130
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.130
Why?
Gene Deletion
2
2008
261
0.130
Why?
Pancreatic Neoplasms
1
2019
206
0.130
Why?
Syndecans
3
2006
37
0.130
Why?
RNA Interference
2
2015
178
0.130
Why?
Aged, 80 and over
7
2021
3226
0.130
Why?
Cell Death
1
2016
175
0.130
Why?
Ribosomal Proteins
1
2016
24
0.130
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
45
0.130
Why?
Proto-Oncogene Proteins
2
2009
145
0.130
Why?
Proteoglycans
3
2006
83
0.130
Why?
Macrophages
2
2022
364
0.130
Why?
Oncolytic Virotherapy
1
2015
18
0.130
Why?
Gene Dosage
2
2013
74
0.120
Why?
Cell Adhesion Molecules
1
2015
86
0.120
Why?
Polysaccharides
1
2015
51
0.120
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
44
0.120
Why?
Receptors, Transferrin
1
2015
16
0.120
Why?
Side-Population Cells
1
2015
3
0.120
Why?
Lentivirus
1
2015
17
0.120
Why?
Serine Endopeptidases
2
2006
51
0.120
Why?
Retinal Dehydrogenase
1
2014
10
0.120
Why?
Receptors, Cell Surface
1
2015
116
0.120
Why?
Adenine
1
2015
31
0.120
Why?
Caspase 3
2
2022
93
0.120
Why?
Serum
1
2014
32
0.120
Why?
Cell Lineage
1
2014
83
0.120
Why?
Proto-Oncogene Proteins c-kit
1
2014
34
0.120
Why?
Translocation, Genetic
4
2021
240
0.110
Why?
Superoxide Dismutase
1
2014
116
0.110
Why?
Tumor Burden
3
2020
130
0.110
Why?
Piperidines
1
2015
99
0.110
Why?
Cyclins
3
2015
38
0.110
Why?
HLA Antigens
1
2014
52
0.110
Why?
Alkaline Phosphatase
2
2011
93
0.110
Why?
Glycoproteins
1
2014
116
0.110
Why?
Repressor Proteins
4
2015
148
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.110
Why?
Leukemia, Plasma Cell
1
2013
32
0.110
Why?
Lactate Dehydrogenases
1
2013
1
0.110
Why?
Phenotype
4
2009
739
0.110
Why?
Genome, Human
2
2021
109
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
62
0.100
Why?
Follow-Up Studies
5
2024
2242
0.100
Why?
Dose-Response Relationship, Drug
4
2020
1372
0.100
Why?
Scavenger Receptors, Class A
1
2013
39
0.100
Why?
Leukemia
1
2013
65
0.100
Why?
Disease Models, Animal
4
2020
1436
0.100
Why?
bcl-X Protein
1
2013
53
0.100
Why?
Heat-Shock Proteins
1
2013
100
0.100
Why?
RNA, Small Interfering
2
2010
208
0.100
Why?
RNA, Neoplasm
3
2007
43
0.100
Why?
Forkhead Transcription Factors
2
2023
110
0.100
Why?
Clinical Trials, Phase III as Topic
2
2012
45
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
22
0.100
Why?
Drug Screening Assays, Antitumor
3
2020
131
0.100
Why?
Activated Protein C Resistance
1
2011
10
0.090
Why?
Factor V
1
2011
11
0.090
Why?
Protein Isoforms
2
2009
116
0.090
Why?
Acetylcysteine
1
2011
101
0.090
Why?
Glucocorticoids
1
2013
230
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
22
0.090
Why?
HLA-A Antigens
2
2007
10
0.090
Why?
Cells, Cultured
6
2015
1571
0.090
Why?
Gene Silencing
2
2007
115
0.080
Why?
Alleles
2
2021
256
0.080
Why?
Epigenesis, Genetic
2
2023
372
0.080
Why?
Thrombosis
1
2012
250
0.080
Why?
Immunophenotyping
5
2010
105
0.080
Why?
K562 Cells
3
2016
40
0.080
Why?
Microtubule-Associated Proteins
1
2009
66
0.080
Why?
Recombinant Proteins
1
2010
476
0.080
Why?
Bone Remodeling
1
2010
149
0.080
Why?
Chromosome Mapping
2
2006
153
0.080
Why?
Thromboembolism
1
2009
55
0.080
Why?
Neoplasm Staging
3
2024
746
0.080
Why?
Mutation
3
2021
1280
0.080
Why?
Lymphocyte Subsets
1
2008
14
0.080
Why?
Receptors, Immunologic
1
2008
35
0.070
Why?
ras Proteins
2
2020
64
0.070
Why?
Angiogenesis Inhibitors
1
2009
183
0.070
Why?
Neoplasm Transplantation
2
2020
86
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
9
0.070
Why?
Patient Selection
1
2009
259
0.070
Why?
Adoptive Transfer
1
2007
30
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
23
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Gene Expression Regulation
2
2022
955
0.070
Why?
Breast Neoplasms
2
2007
1201
0.070
Why?
HEK293 Cells
2
2019
213
0.070
Why?
Cancer Vaccines
1
2007
80
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
71
0.070
Why?
Drug Evaluation, Preclinical
2
2021
145
0.070
Why?
Caspases
1
2007
103
0.070
Why?
Cyclin D
1
2006
18
0.070
Why?
Chromosome Banding
1
2006
18
0.070
Why?
Proportional Hazards Models
2
2024
415
0.070
Why?
Models, Genetic
1
2006
172
0.070
Why?
Palatine Tonsil
2
2003
11
0.070
Why?
Peptides
1
2007
221
0.060
Why?
DNA Damage
1
2008
301
0.060
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
179
0.060
Why?
Data Interpretation, Statistical
1
2006
162
0.060
Why?
Doxorubicin
2
2018
236
0.060
Why?
Protein Kinases
1
2005
71
0.060
Why?
Cyclin D1
1
2005
52
0.060
Why?
Antibody Formation
1
2005
50
0.060
Why?
Protein Biosynthesis
2
2003
232
0.060
Why?
Mice, Inbred C57BL
2
2021
1808
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
71
0.060
Why?
Papillomaviridae
1
2005
103
0.060
Why?
Base Sequence
3
2015
639
0.060
Why?
Carcinoma, Papillary
1
2004
47
0.060
Why?
Transfection
2
2020
356
0.060
Why?
Transcription, Genetic
1
2005
361
0.060
Why?
Mice, Inbred BALB C
2
2019
296
0.060
Why?
Drug Synergism
2
2014
151
0.060
Why?
Genetic Predisposition to Disease
1
2007
511
0.060
Why?
Jurkat Cells
2
2014
27
0.060
Why?
Zebrafish Proteins
1
2003
21
0.060
Why?
Extracellular Matrix Proteins
1
2004
68
0.060
Why?
Adipogenesis
1
2024
49
0.060
Why?
Steroids
1
2024
57
0.050
Why?
Ovariectomy
1
2024
115
0.050
Why?
PPAR gamma
1
2024
65
0.050
Why?
Sequence Analysis, RNA
1
2024
88
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
34
0.050
Why?
Oxidative Phosphorylation
1
2023
41
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Cytogenetic Analysis
1
2023
74
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
30
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
66
0.050
Why?
Chromosome Deletion
1
2023
134
0.050
Why?
Macrophage Activation
1
2022
25
0.050
Why?
Oncogene Proteins, Fusion
1
2002
57
0.050
Why?
Porphyromonas gingivalis
1
2022
14
0.050
Why?
Geography
1
2022
60
0.050
Why?
Computational Biology
2
2020
215
0.050
Why?
Chromatin
1
2023
137
0.050
Why?
Uterine Cervical Neoplasms
1
2005
276
0.050
Why?
Diploidy
3
2007
26
0.050
Why?
Inflammasomes
1
2022
62
0.050
Why?
DNA, Neoplasm
1
2002
143
0.050
Why?
Models, Animal
2
2015
227
0.050
Why?
Mutation Rate
1
2021
35
0.050
Why?
DNA Primers
2
2015
206
0.050
Why?
Clone Cells
1
2021
70
0.050
Why?
Proteins
1
2003
339
0.040
Why?
Genes, Tumor Suppressor
1
2021
73
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
HCT116 Cells
1
2020
21
0.040
Why?
DNA Copy Number Variations
1
2021
109
0.040
Why?
Ovarian Neoplasms
1
2004
450
0.040
Why?
Cytokines
3
2009
606
0.040
Why?
Wnt Signaling Pathway
1
2021
86
0.040
Why?
Double-Blind Method
2
2014
708
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Immunohistochemistry
3
2009
957
0.040
Why?
Software
1
2002
276
0.040
Why?
DNA
1
2023
535
0.040
Why?
Gene Knockout Techniques
1
2019
39
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
Drug Discovery
1
2020
85
0.040
Why?
Crystallography, X-Ray
1
2019
147
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
Protein Conformation
1
2019
162
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Immunotherapy
1
2021
235
0.040
Why?
Mice, Nude
1
2019
248
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Structure-Activity Relationship
1
2020
395
0.040
Why?
Wnt Proteins
2
2013
98
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
78
0.040
Why?
DNA Methylation
1
2023
550
0.040
Why?
Phosphorylation
1
2020
525
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
Autophagy
1
2020
170
0.040
Why?
Cell Cycle Checkpoints
1
2017
29
0.030
Why?
Cross-Sectional Studies
1
2022
1610
0.030
Why?
Cell Hypoxia
1
2016
82
0.030
Why?
Chronic Disease
1
2019
573
0.030
Why?
Biological Transport
1
2016
164
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
40
0.030
Why?
Models, Statistical
2
2008
226
0.030
Why?
Drug Interactions
1
2016
206
0.030
Why?
Cell Line
2
2013
988
0.030
Why?
Mice, Inbred ICR
1
2016
23
0.030
Why?
Transcriptional Activation
1
2016
119
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Pharmacogenetics
2
2006
50
0.030
Why?
Vidarabine
1
2015
9
0.030
Why?
Mitoxantrone
1
2015
8
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
45
0.030
Why?
Vincristine
1
2015
82
0.030
Why?
China
1
2015
90
0.030
Why?
Vaccination
2
2007
280
0.030
Why?
Prednisone
1
2015
101
0.030
Why?
Ligands
1
2015
203
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Molecular Targeted Therapy
1
2016
123
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Microscopy, Fluorescence
1
2015
158
0.030
Why?
Risk Assessment
2
2009
1270
0.030
Why?
Cyclophosphamide
1
2015
168
0.030
Why?
Disulfiram
1
2014
13
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Glucose
1
2016
341
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
36
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
9
0.030
Why?
Chemotherapy, Adjuvant
1
2014
121
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.030
Why?
Isoxazoles
1
2013
14
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
16
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
29
0.030
Why?
Glutathione
1
2014
299
0.030
Why?
Hedgehog Proteins
1
2013
32
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Itraconazole
1
2013
35
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
32
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Azacitidine
1
2013
34
0.030
Why?
Oxidants
1
2013
54
0.030
Why?
ADP-ribosyl Cyclase
2
2003
5
0.030
Why?
Epitopes
1
2013
59
0.030
Why?
Hydrocortisone
1
2013
110
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
93
0.030
Why?
MAP Kinase Signaling System
1
2013
117
0.030
Why?
Prospective Studies
2
2010
2378
0.030
Why?
Hydrogen Peroxide
1
2013
113
0.030
Why?
Histone Deacetylases
1
2013
50
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
128
0.030
Why?
Radiation, Ionizing
1
2013
100
0.020
Why?
Osteoblasts
2
2006
462
0.020
Why?
Transcriptome
1
2014
313
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
45
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Risk
1
2011
324
0.020
Why?
Bone Density Conservation Agents
1
2010
74
0.020
Why?
Diphosphonates
1
2010
90
0.020
Why?
Databases as Topic
1
2009
37
0.020
Why?
Parathyroid Hormone
1
2010
149
0.020
Why?
Lymphocytes
1
2010
149
0.020
Why?
Cytoskeleton
1
2008
39
0.020
Why?
Genotype
1
2009
533
0.020
Why?
Twins
1
2007
20
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Cytological Techniques
1
2007
14
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
226
0.020
Why?
NF-kappa B p50 Subunit
1
2007
16
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
65
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
63
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Antigen Presentation
1
2007
25
0.020
Why?
Benzamides
1
2007
50
0.020
Why?
Remission Induction
1
2007
208
0.020
Why?
Polysaccharide-Lyases
1
2007
6
0.020
Why?
Leukocytes, Mononuclear
1
2007
118
0.020
Why?
Plasmids
1
2007
164
0.020
Why?
Tissue Culture Techniques
1
2007
37
0.020
Why?
Enzyme Activation
1
2007
268
0.020
Why?
Interferon-gamma
1
2007
177
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
234
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Anticoagulants
1
2009
256
0.020
Why?
Piperazines
1
2007
119
0.020
Why?
Neoplasms, Experimental
1
2007
110
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
49
0.020
Why?
Diagnosis, Differential
1
2010
1033
0.020
Why?
Dendritic Cells
1
2007
135
0.020
Why?
Polymerase Chain Reaction
1
2007
449
0.020
Why?
Incidence
1
2009
1032
0.020
Why?
Receptors, Estrogen
1
2007
132
0.020
Why?
Chromosomes, Human
1
2006
39
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Endopeptidases
1
2006
65
0.020
Why?
Rabbits
1
2006
372
0.020
Why?
Coculture Techniques
1
2006
142
0.020
Why?
Combined Modality Therapy
1
2007
641
0.020
Why?
Cyclin D3
1
2005
5
0.020
Why?
Cyclin D2
1
2005
20
0.020
Why?
Trisomy
1
2005
27
0.020
Why?
Adipocytes
1
2006
126
0.020
Why?
Oligonucleotide Probes
1
2004
20
0.010
Why?
Stem Cells
1
2006
166
0.010
Why?
Epithelium
1
2004
66
0.010
Why?
Molecular Sequence Data
1
2006
778
0.010
Why?
Endothelium, Vascular
1
2006
251
0.010
Why?
Ovary
1
2004
103
0.010
Why?
Endothelial Cells
1
2006
258
0.010
Why?
Databases, Factual
1
2007
673
0.010
Why?
Bacterial Proteins
1
2007
367
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
8
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
45
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Cell Separation
1
2003
92
0.010
Why?
Biopsy
1
2005
588
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
NAD+ Nucleosidase
1
2002
3
0.010
Why?
Cell Communication
1
2003
68
0.010
Why?
Antigens, Differentiation
1
2002
17
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
134
0.010
Why?
Cohort Studies
1
2006
1452
0.010
Why?
Immunoglobulins
1
2002
81
0.010
Why?
Database Management Systems
1
2002
28
0.010
Why?
Reproducibility of Results
1
2005
1197
0.010
Why?
Logistic Models
1
2003
900
0.010
Why?
Magnetic Resonance Imaging
1
2003
1548
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description